NHI price approval for 313 new products.

Published: 2004-06-23 06:56:00

Updated: 2004-06-23 06:56:00

On June 19 MOHW announced the revised ordinance of "NHI drug reimbursement and non-reimbursement and the upper limit reimbursement price list" covering 9 drugs for the NHI price changes, 313 new products for the reimbursement schedule including Diblufen 150mg of Charm Pharm. co. (NSAID) and 3 dru...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK